Kincora Commences Drilling at the Wongarbon Porphyry Project

Kincora Commences Drilling at the Wongarbon Porphyry Project

First ever hole to basement geology commenced at the Wongarbon projectDesigned to test a large buried magnetic anomaly interpreted as a gold-copper porphyry targetSeeks to confirm the Wongarbon project hosts one of the few remaining large and untested intrusive complexes of the Macquarie Arc and located within a common transverse structure to the recent 14.7Moz gold equivalent Boda and Kaiser porphyry discoveriesAnticipated 650 metre hole expected to take approximately 4-weeks to completeFunding grant from the New South Wales (NSW) State Government supports an anticipated cost of less than US$100,000 to Kincora shareholdersResults will assist optimise follow up exploration, including Kincora's multi-phase partnership with Fleet Space Technologies' (Fleet Space) utilising its AI-powered ExoSphere platform, which integrates real-time geophysical sensors, proprietary multiphysics surveys, geochemistry and AI-enabled drill targeting into a single workflowFleet Space has the right to earn a minority non-carried interest in the project with drillingMelbourne, Australia--(ACN Newswire via SeaPRwire.com - November 18, 2025) - Gold-copper explorer and hybrid project generator Kincora Copper Limited (ASX: KCC) (TSXV: KCC) ("Kincora" or "the Company") is pleased to have commenced drilling at the Wongarbon porphyry project designed to provide the first ever sample of basement geology and test a prominent magnetic anomaly analogous to the anomalies associated with the largest greenfield discoveries in the Macquarie Arc in recent decades.John Holliday, Technical Committee chair, commented:"There is a good chance that the next Cadia-scale deposit in the Macquarie Arc will be found in the covered and underexplored parts of the Lachlan Fold Belt. This is virgin territory and a major opportunity with huge upside. Regional magnetics has proven very effective in mapping the prospective Macquarie Arc belts and the major porphyry deposits have identifiable magnetic intrusive complex signatures. The Wongarbon project is a real stand out untested example of this signature in the right location and with the right features.I am very excited for Kincora to drill the first hole ever into basement geology at Wongarbon. This hole is set to finally test a target that I had first recognised back in 1996 before the Cadia-Ridgeway and Far East discoveries that year. Wongarbon is a prime candidate for major discovery, and this first hole will provide very valuable information to assist guide follow up activities."Sam Spring, President and CEO and Peter Leaman, VP of Exploration, added:"Wongarbon is an elephant scale target located in elephant country, favorably located near to and potentially associated with the most significant new porphyry system discovery in NSW of recent decades (the Boda-Kaiser deposits).While you can't ever expect to make a discovery with your first hole, regardless this hole will greatly assist follow up exploration and optimise the innovative multi-phase partnership in place with Fleet Space.Coupled with last month's funding grant from the NSW Government, the risk reward scenario is highly compelling and unique on a global perspective. The expected cost of less than US$100,000 to Kincora shareholders compares exceptionally well to similar nature targets requiring budgets of greater than US$1-million in the America's. This hole is in-line with Kincora's capital efficient value add strategy for its sole funded projects and offering shareholders multiple shots on goal with seven different licenses being drilled within a 12-month horizon."BACKGROUNDThe remaining untested intrusive complexes of the Macquarie Arc porphyry geology are a globally significant exploration opportunity as recently indicated by the significant discovery and resource growth by Alkane Resources' at the Boda and Kaiser deposits (now 14.7Moz AuEq) and Evolution Mining at the Cowal mine (taking a resource of 3.4Moz Au at the time of acquisition to now 13.8Moz endowment producing over 330,000oz Au in FY2025).Within the district various exploration groups have been having greenfield and early-stage exploration success at previously untested and open volcano-intrusive complexes of the Macquarie Arc. These groups include AngloGold Ashanti in partnership with Kincora (at the Nyngan, Nevertire South and Nevertire projects), AngloGold Ashanti in partnership with Inflection Resources (at the Duck Creek and Trangie project's), FMG directly and with Magmatic Resources (latter at the Myall project), Gold Fields in partnership with Gold and Copper (privately held around Cadia, drilling commenced), S2 Resources with Legacy Minerals (at the Glenlogan project), Newmont with Koonenburry Gold (at the Fairholme and Junee projects), Gilmore South (LinQ Minerals) and most recently Waratah Minerals (with its new Consols discovery at the Spur project), amongst others.In 2024, Kincora opportunistically pegged the Wongarbon project directly from the NSW State (100% ownership) and has brought in a technical and funding partner (Fleet Space). On October 20th 2025, Kincora announced the award of a grant for up to A$143,483 by the State Government supporting drilling.The award follows a competitive expert panel review process, monies are non-dilutionary and funds drilling on a matched dollar-for-dollar basis. The grant is provided by the Critical Minerals and High-Tech Metals Exploration Program within NSW's Critical Minerals Strategy 2024-35. These programs reiterate a favorable pro-investment and operating environment in NSW, with the Macquarie Arc being Australia's foremost porphyry region and a Tier 1 global copper-gold jurisdiction.The Wongarbon license is interpreted to host one of the very few remaining, completely untested, volcano-intrusive complexes of the Macquarie Arc. The license covers a large (173km2) portion of the interpreted Macquarie Arc geology situated under post mineral cover that has not previously been drill tested or sampled.The Wongarbon project was a priority for drilling in 1996 by Newcrest Mining (led by John Holliday) before the discoveries at Cadia-Ridgeway and Far East (latter now known as Cadia East) within three holes of each other that year. Almost thirty years later, Wongarbon remains undrilled and John Holliday is leading Kincora's exploration strategy at the project and seeking to finally advance the geological understanding of this new district scale opportunity and a compelling large porphyry system target.Figure 1: The Wongarbon project is interpreted to hosts one of the few remaining large and untested intrusive complexes of the Macquarie Arc and be located within a common transverse structure to the recent 14.7Moz gold equivalent Boda and Kaiser porphyry discoveries.Virgin ground on strike and potentially associated with common transverse structures to the best greenfield discoveries in the Macquarie Arc in recent decades + new gen tech partnership with Fleet Space + NSW Government Grant.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/2305/274905_kincora1.jpgBoth Alkane and Magmatic Resources are undertaking exploration and drilling at up to seven targets along a common transverse structure that is interpreted to potentially extend into the Wongarbon license and be a key control to the 14.7Moz AuEq resource inventory at the Boda and Kaiser porphyry copper-gold discoveries.It is well documented that the composite volcanic and intrusive complexes elsewhere in the Macquarie Arc have large alteration and geochemical halos that are identifiable from regional geophysical surveys (features interpreted to be present at the Wongarbon project), with the mineralised deposits generally situated on intrusive level cross-arc structures (such as those currently being tested by Alkane and Magmatic, hosting the Boda-Kaiser deposits, and, interpreted to extend into the Wongarbon project). The latter interpretation is also supported by recent proprietary surveys and interpretation at the Boda-Kaiser deposits by Fleet Space, who Kincora has partnered with to advance the Wongarbon project.The commence drill hole utilises cost effective mud-rotary drilling cover sequence and diamond core drilling in the basement rocks with NQ triple tube diameter diamond core tail. This technique is time and cost effective for gaining initial samples of porphyry-prospective basement and is being used by Kincora in similar terrain in the Northern Junee-Narromine Belt at the Nyngan, Nevertire South and Nevertire projects under the earn-in and joint venture agreements with AngloGold Ashanti.Figure 2: Kincora has commenced drilling the first hole to basement at the Wongarbon project (EL9652) testing southern section of the Wongarbon Magmatic Complex.A ~650m rotary mud-diamond tail hole seeks to test a large buried magnetic anomaly interpreted as a copper-gold porphyry target.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/2305/274905_f3ec9fb3a420a87c_004full.jpgFor further details and technical disclosures on the Wongarbon project, please refer to the following press releases:October 22nd, 2025, "Kincora awarded drilling grant for Wongarbon project"October 15th, 2024, "Kincora announces Strategic Investment & Expanded Partnership with Fleet Space"June 3rd, 2024, "New Major, Completely Unexplored Porphyry Complex and Drill Targets Secured"Further details are available on the NSW Government's Critical Minerals and High-Tech Metals Exploration Program and the Critical Minerals Strategy 2024-35 are available at: https://www.resources.nsw.gov.au/invest-nsw/industry-support.For further details on Fleet Space Technologies, please go to its website at: https://www.fleetspace.com/.For further information, please contact: Sam Spring, President and Chief Executive Officer Laurie Thomas, Strategic Advisorsam.spring@kincoracopper.com or +61431 329 345laurie.thomas@kincoracopper.com or +1306 341 3826 Media Contact Julia Maguire, Managing Director, The Capital Networkjulia@thecapitalnetwork.com.au or +61 2 7257 7338 Executive officeSubsidiary office Australia 400 – 837 West Hastings Street C/- JM Corporate ServicesVancouver, BC V6C 3N6, Canada Level 6, 350 Collins StreetTel: 1.604.283.1722 Melbourne, VIC, Australia 3000 About Kincora: Kincora Copper Limited (ASX: KCC) (TSXV: KCC) is an emerging Australia-focused gold-copper explorer with a hybrid project generator strategy.The Company is successfully proving up the prospectivity of its extensive project portfolio, which includes multiple district-scale landholdings and scalable drill ready targets. These assets are located in Australia's Lachlan Fold Belt and Mongolia's Southern Gobi, two of the globe's leading porphyry belts, and the historical Condobolin mining field within the Cobar Basin in NSW.The Company has already unlocked over $100 million of potential partner funding for multiple earlier stage and/or non-core porphyry projects. These initial deals have supported over 13,500 metres of drilling and over A$6.5m of partner funded exploration since late 2024, with management fees and exploration ramping up.Partner discussions are ongoing for its remaining 100% owned flagship projects that are all situated within existing porphyry camps containing over 20-million-ounce gold equivalent resource inventory.By having a significant portfolio of partner funded large porphyry projects, and a very focused program on a 100% owned Condobolin project, the Company is seeking to position Kincora as a leading institutional grade explorer in the public Australian and Canadian markets, and the leading project generator on the ASX.To find out more, please refer to our 2-page July 2025 corporate strategy: https://kincoracopper.com/corporate-strategy/.The Company's website is: www.kincoracopper.com.This announcement has been authorised for release by the Board of Kincora Copper Limited (ARBN 645 457 763).Qualified Person The scientific and technical information in this announcement was prepared in accordance with the standards of the Canadian Institute of Mining, Metallurgy and Petroleum and National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI 43-101") and was reviewed, verified and compiled by Kincora's staff under the supervision of Peter Leaman (M.Sc. Mineral Exploration, FAusIMM), Senior Vice-President of Exploration of Kincora, and John Holliday (BSc Hons, BEc, member of the Australian Institute of Geoscientists), Non-Executive Director and Chairman of Kincora's Technical Committee, who are Qualified Persons for the purpose of NI 43-101JORC Competent Person StatementInformation in this announcement that relates to Exploration Results, Mineral Resources or Ore Reserves are those that have been previously reported (with the original release referred to in this announcement), in the case of Mineral Resources or Ore Reserves the material assumptions and technical parameters underpinning the estimates have not materially changed, and have been reviewed and approved by John Holliday and Peter Leaman, who are Competent Persons under the definition established by JORC and has sufficient experience which is relevant to the style of mineralisation and type of deposit under consideration and to the activity being undertaking to qualify as a Competent Person as defined in the 2012 Edition of the 'Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves'. John Holliday and Peter Leaman consents to the inclusion in this report of the matters based on his information in the form and context in which it appears. The review and verification process for the information disclosed herein for the Nyngan Projects have included the receipt of all material exploration data, results and sampling procedures of previous operators and review of such information by Kincora's geological staff using standard verification procedures.Forward-Looking StatementsCertain information regarding Kincora contained herein may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements may include estimates, plans, expectations, opinions, forecasts, projections, guidance or other statements that are not statements of fact. Although Kincora believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Kincora cautions that actual performance will be affected by a number of factors, most of which are beyond its control, and that future events and results may vary substantially from what Kincora currently foresees. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration results, continued availability of capital and financing and general economic, market or business conditions. The forward-looking statements are expressly qualified in their entirety by this cautionary statement. The information contained herein is stated as of the current date and is subject to change after that date. Kincora does not assume the obligation to revise or update these forward-looking statements, except as may be required under applicable securities laws.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the Australian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274905 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
华商能源绿色甲醇斩获欧盟市场准入证

华商能源绿色甲醇斩获欧盟市场准入证

香港, 2025年11月18日 - (亚太商訊) - 11月18日,由招商局工业集团主办、华商能源科技股份有限公司承办的第五届世界航商大会船舶智造专题论坛在香港举行。会上,华商能源(00206.HK)正式发布绿色甲醇项目,该项目当日斩获国际权威认证机构颁发的国际可持续发展和碳认证(ISCC EU)。这也意味着华商能源绿色甲醇产品获得欧盟准入证,为项目进入国际市场奠定坚实基础。华商能源绿色甲醇项目的平均温室气体排放强度较化石燃料制甲醇降低70%以上,可满足国内港口国际航运船舶绿色燃料加注需求。项目首期年产绿甲量为2万—3万吨,可满足2艘24000标箱的集装箱船一年的燃料需求,预计今年12月开始交付。项目完成技术升级后年产量将达6万吨。随着航运业向低碳、净零方向转型成为全球共识,绿色甲醇成为航运减排核心选项。华商能源相关负责人介绍,华商能源联合山东能源集团打造山东济宁绿色甲醇工厂,利用现有煤制甲醇装置,采用核心工艺技术包进行设备改造,通过煤基工艺掺烧生物质的技术路径生产绿色甲醇。这一创新路径不仅保留了现有装置的产能,还大幅提高了温室气体减排强度,破解了传统化工低碳转型的"重投资困境"。目前,该项目原料收集及生物炭制备、绿色甲醇生产等环节,均顺利通过ISCC严格认证,成为全球首个按照ISCC Co-processing V2.0指导文件全流程认证的绿色甲醇项目。此次认证落地,不仅打通了国产绿色甲醇的全球市场通道,更以轻资产、高合规的共处理模式,为全球传统化工企业低碳转型提供可复制路径。招商局工业集团董事长吴四川表示,绿色科技是招商局集团"第三次创业"中三大战略性新兴产业方向之一。招商工业将扮演"制造场景落地与装备创新平台"的双重角色,华商能源则扮演绿色能源装备与能源供应的"排头兵"。招商工业致力于打造成为一家以科技创新为驱动、以数字化转型为引领、以精益管理为基础的成本领先的绿色化科技型制造企业,为推动船舶工业的高质量发展,服务加快建设交通强国、海洋强国。当日,国际权威认证机构法国必维集团为华商绿能颁发了绿色甲醇ISCC EU认证证书。厦门大学教授、嘉庚创新实验室主任郑南峰,全球甲醇燃料协会首席执行官亚历山大·多尔,法国船级社企业事务总监尼古拉斯·布朗,招商工业集团总经理梅先志,招商局集团战略发展部(科技创新部)副总经理李弘远,招商工业副总经理、华商能源董事长梅中华,华商能源董事张真等出席颁证仪式。作为招商局集团发展绿色科技的重要平台之一,华商能源正在以"氢醇氨"为主要赛道加大布局绿色能源产业的力度,聚焦能源装备制造和能源供应服务,致力于打造中国领先的船用绿色能源与装备综合服务商。下一步,华商能源将继续携手合作伙伴,持续扩大绿色甲醇产能,推动构建从原料收集到产品加注的完整绿色甲醇产业链,推动绿色甲醇在全球市场的广泛应用。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Icarus’ Future: A Miami-Born Campaign Telling COP30 Leaders Our Children’s Future is at Stake – Just Won Seven LUUM Awards

Icarus’ Future: A Miami-Born Campaign Telling COP30 Leaders Our Children’s Future is at Stake – Just Won Seven LUUM Awards

MIAMI, FL, Nov 18, 2025 - (ACN Newswire via SeaPRwire.com) - Our Present, Icarus' Future reframes the delay on climate action by centering parents, children, and human stories - using a visceral installation, a global petition, and an art contest to translate feeling into civic pressure ahead of COP30. Because the policy choices made today will determine the life chances of children born this year.Born on climate-vulnerable Miami Beach and amplified at Climate Week NYC, Our Present, Icarus' Future uses immersive storytelling to reveal how rising heat, sea-level rise, pollution, and extreme weather affect a child's lifetime to demand enforceable emissions cuts, an end to fossil-fuel subsidies, and limits on industry lobbying.By connecting the cautionary myth of Icarus to today's climate crisis, the campaign not only is raising awareness but also mobilizing public support to put pressure on world leaders to act decisively. To date, it has engaged an estimated 38.2 million people across digital and traditional media platforms, received tens of thousands of petitions, and just won seven LUUM Awards (2 Gold, 5 Silver), recognized across Causes, Human Rights and Health categories.The campaign is supported by Zubi, a creative agency specializing in culturally resonant, impact-driven work, and by VoLo Foundation, a family philanthropy that accelerates evidence-based climate solutions and community education."Winning at LUUM validates something we already believed: art can move people… and people move policy," said Yoca Arditi-Rocha, CEO of The CLEO Institute. "Today, as negotiators gather in Brazil, we ask leaders to make the hard choices: cut planet-warming emissions, end taxpayer subsidies for fossil fuel pollution, and keep industry lobbyists out of global climate talks. "World leaders: you are guardians of the future, not its auctioneers. At COP30, choose children over corporate profit. Every heartbeat matters.""CLEO has masterfully used the myth of Icarus as a timely metaphor for the climate crisis. Just as Icarus' wings melted when he flew too close to the sun, our planet is at risk of a similar fate if we ignore the warnings of scientists. Icarus as a child, symbolizes the next generation who will inherit the world shaped by today's choices," said Thais Lopez Vogel, cofounder and trustee of VoLo Foundation."I think as humans, we've grown indifferent to messages. We're bombarded with information every day, tied to multiple screens, and we no longer take the time to really listen. We've become immune. To break through that noise, we have to be disruptive and be unexpected. Our approach was to use a "voice" that didn't speak with words, but whose life carried the message. A silent messenger, a baby, life itself, that made people stop and finally listen." said Iván Calle, VP Executive Creative Director of ZubiPolicy demands at COP30Enforceable, rapid emissions reductions and an accelerated pathway to phase out fossil fuels.An end to fossil-fuel subsidies and public financing that incentivizes planet-warming pollution.Safeguards that limit special-interest influence and prevent fossil-industry lobbying from shaping UN climate negotiations.Learn more at: Act4Icarus.orgWhy this matters nowPublic funding continues to prop up the problem: fossil fuels receive roughly $1.5 trillion annually in direct subsidies and when indirect costs such as health and climate damages are included, support swells to roughly $7 trillion a year. Also, recent reporting last week shows a heavy fossil-fuel lobby presence at COP30; a dual political and financial barrier for these negotiations and the reason this campaign matters most now.Cities and regions like Miami already face rising costs and compounding disaster risk: home-insurance rates, infrastructure strain, displacement and disproportionate impacts on frontline communities. With the US absent in this global stage, the world is watching COP30. Political choices made this November will shape whether nations accelerate an equitable transition or bake in greater harm for future generations. The time is now. Later will be too late.Media opportunitiesCLEO can provide on-camera interviews and a mother-centered story at COP30, campaign assets, video, petition and contest data.About The CLEO InstituteThe CLEO Institute is a women-led, nonpartisan nonprofit turning climate science into action through education, advocacy, and community engagement. Florida-born and nationally recognized, CLEO has educated 62,000+ people in climate science, unlocked millions for local and state solutions, and is known for creative, award-winning campaigns. CLEO partners with government, business, academic, and community leaders to combat misinformation, mobilize civic power, and advance resilient climate policies.About ZUBIzubiad.com is a multicultural communications agency founded by Tere A. Zubizarreta in Miami over 50 years ago, which is now part of WPP's network. The agency is recognized as a pioneer in multicultural marketing in the USA.About VoLo FoundationVoLo Foundation is a private nonprofit Foundation with a mission to accelerate change and global impact by supporting science-based climate solutions, enhancing education, and improving health.About the LUUM AwardsThe LUUM Awards celebrate the world's best purpose-driven creative work - honoring campaigns that combine creativity with measurable social and environmental impact. LUUM's 2025 edition recognized agencies, NGOs and brands across five continents for outstanding communications that change hearts and minds.Contact InformationJocelyn MahoneCommunications Managerjmahone@cleoinstitute.org305-573-5251SOURCE: The CLEO InstituteRelated ImagesMothers Carrying Our FutureMothers at Icarus Activation at Miami BeachRelated Documents:icarus-petition-flyer.pdfFINAL_CLEO-Institute-Icarus-Action-Toolkit-Organizations.9.18.pdfEN ESPAÑOL - PRESS RELEASE.pdf Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Radisson Announces Exercise of Warrants

Radisson Announces Exercise of Warrants

Rouyn-Noranda, Quebec--(ACN Newswire via SeaPRwire.com - November 17, 2025) - Radisson Mining Resources Inc. (TSXV: RDS) (OTCQX: RMRDF) ("Radisson" or the "Company") is pleased to announce that it has received total gross proceeds of C$1,481,694.12 from the exercise of 5,487,756 class A shares purchase warrants (the "Warrants") at a price of $0.27 per warrant. The Warrants were issued in relation to a private placement completed in November 2023 and had an expiry of November 17, 2025.Furthermore, the Company has received additional total gross proceeds of C$42,126.72 from the early exercise of 113,856 class A shares purchase warrants (the "Warrants") at a price of $0.37 per warrant. The warrants were issued in relation to a private placement completed in October 2024.Matt Manson, President and CEO, commented: "The exercise of these warrants, held by long-standing and supportive shareholders, further strengthens Radisson's financial position and supports the Company's ongoing growth initiatives. At the end of October, our treasury stood at approximately C$36 million, fully funding our ongoing 140,000 metre step out drill program at the O'Brien Gold Project."As of today, 5,430,431 warrants remain outstanding at an exercise price of $0.37, with expiry dates ranging from October 22, 2026, to October 29, 2026. If fully exercised, these warrants represent potential gross proceeds of C$2,009,259.47. No warrants were issued in connection with the Company's C$12 million private placement, completed in May 2025, nor in the most recent C$25 million private placement, completed in October 2025.Radisson Mining Resources Inc.Radisson is a gold exploration company focused on its 100% owned O'Brien Gold Project, located in the Bousquet-Cadillac mining camp along the world-renowned Larder-Lake-Cadillac Break in Abitibi, Québec. A July 2025 Preliminary Economic Assessment described a low cost and high value project with an 11-year mine life and significant upside potential based on the use of existing regional infrastructure. Indicated Mineral Resources are estimated at 0.58 million ounces (2.20 million tonnes at 8.2 g/t Au), with additional Inferred Mineral Resources estimated at 0.93 million ounces (6.67 million tonnes at 4.4 g/t Au). Please see the NI 43-101 "O'Brien Gold Project Technical Report and Preliminary Economic Assessment, Québec, Canada" effective June 27, 2025, and other filings made with Canadian securities regulatory authorities available at www.sedarplus.ca for further details and assumptions relating to the O'Brien Gold Project.For more information on Radisson, visit our website at www.radissonmining.com or contact:Matt MansonPresident and CEO416.618.5885mmanson@radissonmining.comKristina PillonManager, Investor Relations604.908.1695kpillon@radissonmining.comForward-Looking StatementsThis news release contains "forward-looking information" within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates, projections, and interpretations as at the date of this news release. Forward-looking statements including, but are not limited to, statements with respect to the ability to execute the Company's plans relating to the O'Brien Gold Project as set out in the Preliminary Economic Assessment; the Company's ability to complete its planned exploration and development programs; the absence of adverse conditions at the O'Brien Gold Project; the absence of unforeseen operational delays; the absence of material delays in obtaining necessary permits; the price of gold remaining at levels that render the O'Brien Gold Project profitable; the Company's ability to continue raising necessary capital to finance its operations; the ability to realize on the mineral resource and mineral reserve estimates; assumptions regarding present and future business strategies; local and global geopolitical and economic conditions and the environment in which the Company operates and will operate in the future; planned and ongoing drilling; the significance of drill results; the ability to continue drilling; the impact of drilling on the definition of any resource; and the ability to incorporate new drilling in an updated technical report and resource modelling; the Company's ability to grow the O'Brien Gold Project; and the ability to convert inferred mineral resources to indicated mineral resources. Any statement that involves discussions with respect to predictions, expectations, interpretations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "interpreted", "management's view", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information. Except for statements of historical fact relating to the Company, certain information contained herein constitutes forward-looking statements Forward-looking information is based on estimates of management of the Company, at the time it was made, involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the companies to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others; the risk that the O'Brien Gold Project will never reach the production stage (including due to a lack of financing); the Company's capital requirements and access to funding; changes in legislation, regulations and accounting standards to which the Company is subject, including environmental, health and safety standards, and the impact of such legislation, regulations and standards on the Company's activities; price volatility and availability of commodities; instability in the global financial system; the effects of high inflation, such as higher commodity prices; the risk of any future litigation against the Company; changes in project parameters and/or economic assessments as plans continue to be refined; the risk that actual costs may exceed estimated costs; geological, mining and exploration technical problems; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; risks relating to the drill results at O'Brien; the significance of drill results; and the ability of drill results to accurately predict mineralization. Although the forward-looking information contained in this news release is based upon what management believes, or believed at the time, to be reasonable assumptions, the parties cannot assure shareholders and prospective purchasers of securities that actual results will be consistent with such forward-looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended, and neither the Company nor any other person assumes responsibility for the accuracy and completeness of any such forward-looking information. The Company believes that this forward-looking information is based on reasonable assumptions, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this press release should not be unduly relied upon. The Company does not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward-looking information contained herein to reflect new events or circumstances, except as may be required by law. These statements speak only as of the date of this news release.Please refer to the "Risks and Uncertainties Related to Exploration" and the "Risks Related to Financing and Development" sections of the Company's Management's Discussion and Analysis dated April 29, 2025 for the year ended December 31, 2024, and the Company's Management's Discussion and Analysis dated August 27, 2025 for the three-month period ended June 30, 2025, all of which are available electronically on SEDAR+ at www.sedarplus.ca. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274899 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions

Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions

SUNNYVALE, CA, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Graid Technology today announced the successful completion of its agreement with Intel Corporation to license the rights to market, sell, and develop Intel® Virtual RAID on CPU (Intel® VROC). The successful completion of this transaction marks a significant milestone that accelerates Graid Technology's progress toward profitable growth and delivering on its vision for the future of enterprise storage.Graid Technology Finalizes Intel® VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions"This agreement represents an exciting new chapter for Graid Technology and for the global ecosystem that relies on Intel® VROC," said Leander Yu, CEO of Graid Technology. "Finalizing the deal allows us to ensure long term continuity for existing customers while also accelerating innovation and value creation across the enterprise storage market."Since the initial announcement, Graid Technology has engaged in productive discussions with many VROC customers, OEMs, and channel partners who have expressed strong support and enthusiasm for the transition."Customer response has been overwhelmingly positive," added Thomas Paquette, Sr. Vice President and GM, Americas & EMEA at Graid Technology. "Partners and system builders see this transition as a win win; protecting their current investments in Intel® VROC while benefiting from Graid Technology's focus, agility, and commitment to high performance storage innovation."Under the terms of the agreement, Graid Technology has assumed responsibility for Intel® VROC customer support and development pipeline, ensuring uninterrupted service and expanding collaboration opportunities across new storage and data infrastructure markets. At this time, Graid Technology has not established a roadmap for new feature enhancements to Intel® VROC, but the team is actively listening to customer feedback and prioritizing their ongoing needs.For more information about Intel® VROC and Graid Technology's enterprise storage solutions, visit https://graidtech.com/vroc.Media Inquiries:Andrea EakenGraid Technology Sr. Director of Marketing, Americas & EMEAandrea.eaken@graidtech.comContact InformationAndrea EakenSenior Director of Marketing, Americas & EMEAandrea.eaken@graidtech.com949-742-9928SOURCE: Graid Technology Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
JBM Healthcare Announces FY2026 Interim Results

JBM Healthcare Announces FY2026 Interim Results

KEY HIGHLIGHTS- Revenue increased 7.7% year-on-year to HK$429.6 million- Gross profit rose 23.2% to HK$253.6 million- Profit attributable to equity shareholders increased 20.0% to HK$115.0 million- Declared an interim dividend of HK9.75 cents per share- Ho Chai Kung and Po Chai Pills achieved steady growth supported by strong marketing and brand execution- Cross-border e-commerce and concentrated Chinese medicine granules (CCMG) businesses remained resilient and contributed to stable performanceHONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Company”, Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, today announced its interim results for the six months ended 30 September 2025 (“FY2026 Interim” or the “Reporting Period”).Despite a challenging retail environment, JBM Healthcare delivered moderate growth, with revenue increasing by 7.7% to HK$429.6 million and profit attributable to equity shareholders rising by 20.0% to HK$115.0 million during the Reporting Period. The solid performance was underpinned by the strength of its flagship proprietary brands, diversified product portfolio, and disciplined execution. The Group continued to enhance brand equity and expand market reach through integrated marketing, e-commerce expansion, and strategic engagement initiatives across Hong Kong and the Greater Bay Area.Resilient Performance across Core SegmentsDuring the Reporting Period, the Branded Medicines segment achieved solid growth, led by the sustained momentum of Ho Chai Kung. Building on its reputation as a trusted over-the-counter remedy for pain and fever, the brand further strengthened its market presence through a series of high-impact marketing initiatives.Television advertising featuring brand ambassador Hins Cheung enhanced brand awareness and consumer engagement, while strategic sponsorships and event partnerships broadened audience reach. The brand also gained strong visibility through its participation in large-scale televised events, effectively connecting with both middle-aged and younger consumers.The Proprietary Chinese Medicines segment recorded notable growth, led by Po Chai Pills and supported by the CCMG business.During the period, Po Chai Pills launched its innovative “tear-and-take” sachet pack designed for convenient, on-the-go use. A lively TV commercial featuring Louis Koo, Tony Wu , and Bonnie Wong captured strong public attention, blending nostalgic charm with modern visuals and achieving millions of online views within weeks of launch, adding momentum for the brand. Complemented by community campaigns, youth outreach, and large-scale outdoor visibility, these initiatives further strengthened Po Chai Pills’ relevance across generations.The Health and Wellness Products segment recorded a moderate decline due to the rationalisation of certain products, partially offset by the solid and steady growth of the Oncotype DX Breast Cancer Recurrence Score Test. The test’s adoption continued to expand in both Hong Kong and Macau. Supported by ongoing collaboration with the Hong Kong Breast Cancer Foundation, the Group further advanced public education on genomic testing and precision medicine, reinforcing Oncotype DX’s position as a trusted diagnostic assay test that provides individualised data on tumor biology , helping doctors tailor a treatment plan specifically to the individual, ensuring appropriate therapy and increasing confidence in treatment decisions. Expanding E-Commerce and TCM Market OpportunitiesDuring the Reporting Period, the Group further expanded its presence across leading cross-border e-commerce platforms such as Tmall Global, JD.com, and Alibaba Health. Ho Chai Kung and Po Chai Pills continued to perform strongly online. These efforts enhanced brand awareness, customer perceptions and product acceptance amongst the target prospects in Chinese MainlandIn the traditional Chinese medicine (TCM) market, the Group maintained stable performance in its CCMG business, supplying over 700 single- and combo-formula granules to a wide network of registered practitioners. To capture new market opportunities, JBM Healthcare is expanding its TCM portfolio with new products and an upgraded e-business platform designed to streamline ordering processes, enhance practitioner engagement, and integrate online and offline service experiences.Mr. Derek Sum, Executive Director of JBM Healthcare, commented, “Amid a challenging market, we sustained growth through disciplined execution and the continued strength of our flagship brands. Our diversified portfolio and expanding e-commerce footprint have reinforced JBM Healthcare’s resilience and competitiveness. Looking ahead, we will continue to enrich our product mix, deepen customer engagement, and capture opportunities across Hong Kong, the Greater Bay Area, and other key markets to deliver sustainable long-term value.”About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Tin Hee Tong Tin Hee Pills, Contractubex, Tong Tai Chung Woodlok Oil , Flying Eagle Woodlok Oil , Saplingtan , Shiling Oil and Konsodona Medicated Oil . JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hkFor media inquiries, please contact:Strategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email: vicky.lee@sprg.com.hkRachel KoTel: (852) 2114 2370Email: rachel.ko@sprg.com.hkCoco YuTel: (852) 2864 4876Email: coco.yu@sprg.com.hk Fax: (852) 2527 1196 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
健倍苗苗公布二零二六财政年度中期业绩

健倍苗苗公布二零二六财政年度中期业绩

业绩亮点- 收益按年增长7.7%至4.3亿港元- 毛利上升23.2%至2.5亿港元- 股东应占溢利上升20.0%至1.15亿港元- 宣派中期股息每股9.75港仙- 旗舰品牌何济公及保济丸在高效的市场推广及品牌执行策略带动下持续稳健增长- 跨境电商及中药配方颗粒业务保持稳定,为整体表现作出贡献香港, 2025年11月17日 - (亚太商訊) - 健倍苗苗(保健)有限公司(「健倍苗苗」或「本公司」,股份代号:2161,连同其附属公司统称「集团」),作为香港领先的品牌保健产品市场推广及分销商,今日公布截至二零二五年九月三十日止六个月(「二零二六财年中期」或「报告期」)之中期业绩。尽管零售环境仍具挑战,集团于报告期内录得稳健增长,收益上升7.7%至4.3亿港元,股东应占溢利上升20.0%至1.15亿港元。业绩表现主要受惠于旗下旗舰自主品牌的持续动力、多元化产品组合以及严谨的执行力。集团继续透过综合市场推广、电子商贸拓展及策略性互动合作,进一步强化品牌资产并扩展于香港及大湾区的市场覆盖。业务板块表现稳健报告期内,品牌药业务录得稳定增长,主要由于旗舰品牌何济公的持续动力带动。凭借其作为家传户晓的止痛退烧良药的信誉,品牌透过一系列具影响力的市场推广活动强化市场地位。由品牌代言人张敬轩先生演出的电视广告提升了品牌知名度与强化了消费者互动,而策略性的赞助与活动合作则扩大了受众覆盖范围。该品牌亦通过赞助知名电视节目获得了高度曝光,有效触及中高龄与年轻消费者群体。品牌中药业务表现同样理想,由保济丸的出色增长带动,并受中药配方颗粒业务的稳定贡献支持。报告期内,保济丸推出全新「条装版」包装,「一撕即食」,即撕开包装便可服用,为消费者带来便携便利的新体验。由古天乐先生带领、加上胡子彤先生及黄正宜小姐演出的广告,以轻松幽默的手法展现产品特色,融合怀旧与现代视觉美感,上线短短数周即录得数百万观看次数,进一步巩固品牌动力。品牌并透过校园互动活动、小区文化展览及大型户外广告,加强跨世代的市场渗透及消费者共鸣。健康及保健产品业务录得温和下跌,主要由于对部分产品进行整合,但Oncotype DX乳癌复发基因检测持续稳健增长,并抵销部分跌幅。该检测于香港及澳门的应用持续扩大。在与香港乳癌基金会的持续合作支持下,集团进一步推广基因组检测及精准医疗的公众教育,巩固Oncotype DX作为可靠诊断检测的地位。此检测能提供肿瘤生物学的个体化数据,协助医生制定专属的治疗方案,确保患者获得适切治疗,并提升治疗决策的信心。拓展电商版图及中医药市场机遇报告期内,集团进一步扩展于跨境电商平台的布局,包括天猫国际、京东及阿里健康等主要电商渠道。何济公及保济丸在在线渠道表现持续强劲。这些举措有效提升了中国内地目标潜在客户对品牌的认知度、好感度及对产品接受程度。于中医药市场方面,集团的中药配方颗粒业务维持稳定表现,为香港超过700名注册中医师提供单方及复方颗粒产品,凭借稳定质量与可靠供应获业界广泛信任。为进一步扩大市场覆盖,集团正积极开发新产品并推出升级版电子商贸平台,以提升订单流程效率、强化与中医师及诊所的互动,并整合在线线下服务体验,推动业务长远增长。健倍苗苗执行董事岑广业先生表示:「在具挑战的市场环境下,我们凭借审慎执行力与品牌实力,持续录得稳健增长。凭借多元化的产品组合与日益扩大的电商版图,我们的韧性与市场竞争力得到进一步提升。展望未来,我们将丰富产品组合、深化客户互动,并把握香港及大湾区以至其他重点市场的机遇,为持份者缔造可持续的长期价值。」有关健倍苗苗(保健)有限公司 (股份代号:2161)健倍苗苗是设于香港的品牌医疗保健品推广及分销公司,产品据点遍及大中华、东南亚及其他选定国家。集团拥有丰富的营销专业知识并具备深厚的制药背景,秉承产品功效和质量至上的优良传统,在行业内定位独特,致力于满足消费者的保健需要。作为本地领先的品牌医疗保健品运营商,集团拥有一广泛系列品牌医疗保健品,包括品牌药、品牌中药及健康保健品,其中包括「保济丸」、「何济公止痛退热散」、「天喜堂天喜丸」、「德国秀碧除疤膏」、「唐太宗活络油」、「飞鹰活络油」、「十灵丹」、「十灵油」及「镇痛霸祛风活络油」等家喻户晓的传统品牌。而自2021年 5月27日,集团获纳入 MSCI 香港微型股指数成份股。有关集团详情,请浏览:www.jbmhealthcare.com.hk传媒查询:纵横财经公关顾问有限公司李惠儿电话: (852) 2864 4834电邮: vicky.lee@sprg.com.hk高文萱电话: (852) 2114 2370电邮: rachel.ko@sprg.com.hk余淑媛电话: (852) 2864 4876电邮: coco.yu@sprg.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

TAIPEI, TAIWAN, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology.Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma.To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to experimental therapies that have the potential to treat these diseases. In the United States, a rare disease is defined as any condition that affects fewer than 200,000 patients. After granting Orphan Drug Designation, the US FDA qualifies companies or drug developers incentives such as tax credits for clinical trials, exemption from user fees, and marketing exclusivity2.In August 2025, OBI launched a phase I/II clinical trial in the United States and Taiwan, recruiting patients with advanced solid tumors. The objectives of the trial are to study the safety, pharmacokinetics, and preliminary efficacy profile of OBI-902 in these patient populations.Heidi Wang, Ph.D, OBI Pharma's Chief Executive Officer noted, "Based on our preclinical data, OBI-902 has several important advantages over other TROP2 ADCs either approved or in development; including high stability in blood circulation, excellent bystander effect that extends the killing to neighboring cancer cells lacking TROP2 expression, potential ability to overcome drug resistance, and outstanding activity in animal and organoid models of cancer. Importantly, this marks the first time an ADC that incorporates OBI's proprietary GlycOBI® ADC technology is being evaluated in patients, including those diagnosed with cholangiocarcinoma. We look forward to investigating this potential best-in-class TROP2 ADC in the clinic."About OBI-902OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells and with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the US FDA on April 30, 2025.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive, worldwide (except in China) license to a TROP2 targeting antibody amino acid sequence. Biosion holds exclusive rights to that antibody sequence in China. OBI holds worldwide commercial rights to OBI-902, except for the rights pertaining to the antibody in China.About GlycOBI®OBI has developed a unique clinical stage, glycan-based site-specific ADC technology (GlycOBI®), which is in a ‘Plug and Play' format and compatible with any antibodies, linkers, and payloads in drug-antibody ratio (DAR) up to 16. Utilizing OBI's proprietary dual-function enzyme (EndoSymeOBI®) and linker technology (HYPrOBI®), homogenous ADCs are manufactured with an efficient and scalable process under GMP conditions. The conjugation process of GlycOBI® avoids disrupting the antibody structure and ensures the ADC has similar biophysical characteristics to the native antibody. Furthermore, OBI's linker technology has improved conjugation efficiency of the payload, reduced aggregation propensity, which provides advantages on manufacturing ADC products. GlycOBI® conjugated ADCs have overcome the limitations of traditional ADCs and achieved better antitumor activity and stability in various in vivo animal studies. GlycOBI®, EndoSymeOBI®, and HYPrOBI® are part of the armamentarium of OBI's Obrion™ ADC Enabling Technologies that also include ThiOBI® and GlycOBI DUO™. OBI-902 is the first ADC utilizing OBI's Obrion™ ADC enabling technology for evaluation of safety and efficacy in Cancer, currently under Phase I/II clinical trial in the US and Taiwan.About OBI PharmaOBI is a clinical stage global oncology company that is headquartered in Taiwan and established in 2002. Its mission, together with its wholly owned subsidiary OBI Pharma USA, Inc., is to develop novel therapeutic agents for patients with high unmet medical needs.OBI's primary focus is the development of novel ADCs, including the first-generation cysteine-based TROP2 ADC, OBI-992. Using the company's proprietary ADC enabling technology, GlycOBI®, powered by EndoSymeOBI® and HYPrOBI®; OBI has created its next-generation novel ADC pipeline, including monospecific: OBI-902 (TROP2), OBI-904 (Nectin-4), bispecific single payload (HER2 x TROP2), and bispecific, dual payload (cMET x HER3) ADCs. To broaden the applicability of linker technology, HYPrOBI®, OBI further developed a novel ThiOBI® platform to enable irreversible cysteine-based conjugation. Additionally, OBI's pipeline includes the first-in-class AKR1C3-targeted small-molecule prodrug OBI-3424, which selectively releases a potent DNA-alkylating antitumor agent in the presence of the aldo-keto reductase 1C3 (AKR1C3) enzyme that is highly expressed in tumors. Additional information can be found at www.obipharma.com.GlycOBI®, EndoSymeOBI®, ThiOBI® and HYPrOBI®are registered trademarks of OBI Pharma. Obrion™ and GlycOBI DUO™ are trademarks under registration.1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-productsForward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Kevin Poulos, Chief Business OfficerOBI Pharma USA, Inc.+1 (619) 537 7698, ext. 102kpoulos@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定

OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定

台北,台湾, 2025年11月17日 - (亚太商讯 via SeaPRwire.com) - 浩鼎(4174.TWO)宣布,收到美国食品药品监督管理局(US FDA)通知,其TROP2靶向ADC新药OBI-902已获准用于治疗胆管癌(Cholangiocarcinoma)的“孤儿药(Orphan Drug Designation)”资格认定。OBI-902为浩鼎自主研发、采用糖位点特异性偶联技术的新型ADC。胆管癌是一种罕见且致死率高的恶性肿瘤,在美国的患者人数少于五万人。根据疾病分期、组织类型及发病部位不同,其五年生存率约为2%至23%¹。目前,美国FDA尚未批准任何用于胆管癌的ADC药物上市销售。为鼓励企业开发治疗罕见疾病的新药,美国FDA设立了“孤儿药”资格认定制度。符合条件的潜在新药经审核通过后,可获得多项政策支持,包括临床支出税务优惠、注册申请费用减免,以及市场独占期等²。在美国,罕见疾病被定义为患者人数少于二十万人的疾病。浩鼎已于2025年8月在美国及台湾启动OBI-902 I/II期临床试验,招募晚期实体瘤患者,旨在评估该药物的安全性、药代动力学特征及初步疗效。浩鼎首席执行官王慧君博士表示:“基于临床前研究,OBI-902相比已上市或研发中的其他TROP2 ADC展现了多项优势,包括在血液循环中具有高稳定性、具备对周围未表达TROP2癌细胞的杀伤能力(旁观者效应),并具备克服耐药性的潜力。在动物试验和类器官肿瘤模型中均表现出优异的药物活性。更重要的是,这是浩鼎首次在临床上应用独家专利GlycOBI® ADC关键技术,其中包含胆管癌患者。我们期待临床试验进一步证实OBI-902具备成为同类最佳(best-in-class)的潜力。”About OBI-902OBI-902 是一款以 TROP2 为靶向的抗体-药物偶联物(ADC)新药,携带强效拓扑异构酶 I 抑制剂用于杀伤肿瘤细胞,药物抗体比例(Drug-Antibody Ratio, DAR)为 4。TROP2 在乳腺癌、肺癌、胆道癌(胆管癌)、卵巢癌、胃癌等多种实体瘤中均呈高表达,被视为理想的抗癌靶点。OBI-902 采用浩鼎专利 GlycOBI® 糖位点特异性技术,具备良好的稳定性和亲水性。在多种动物模型中显示出显著的抗肿瘤功效、良好的安全性及优异的药代动力学特性。其临床试验申请(IND)已于 2025 年 4 月 30 日获美国 FDA 批准。浩鼎于 2021 年 12 月自博奥信生物技术公司(Biosion, Inc., www.biosion.com)引进 TROP2 抗体。根据合约条款,博奥信保留该抗体在中国境内的相关权利。除中国境内抗体权利外,浩鼎拥有 OBI-902 的全球商业化权利。About GlycOBI®浩鼎开发的 GlycOBI® 糖位点特异性 ADC 技术已应用至临床阶段,具备“即插即用”特性,可兼容多种抗体、连接子(linkers)和药物(payloads),其 DAR 可高达 16。透过自主研发的双功能酶 EndoSymeOBI® 及高亲水性连接子技术 HYPrOBI®,可在 GMP 工艺下高效量产均一化 ADC。该偶联过程可避免破坏抗体结构,同时确保 ADC 具备与天然抗体相似的生物特性。HYPrOBI® 高亲水性连接子可提高偶联效率、降低生产过程中不均匀聚集风险,使 ADC 制程具更高优势。多项动物实验显示,采用 GlycOBI® 偶联的 ADC 在抗肿瘤活性与稳定性上均优于传统 ADC。GlycOBI®、EndoSymeOBI® 和 HYPrOBI® 属于浩鼎 Obrion™ ADC 专利技术组合的一部分,另包含 ThiOBI® 与 GlycOBI DUO™。OBI-902 为首款采用 Obrion™ ADC 关键技术进入临床评估的新药,目前已在美国及台湾开展 I/II 期临床试验,以评估其在癌症治疗中的安全性和疗效。About OBI Pharma浩鼎(OBI Pharma, Inc.)成立于 2002 年,总部位于台湾,是一家产品已进入临床阶段的全球肿瘤新药研发公司。浩鼎及其全资子公司 OBI Pharma USA, Inc. 的使命,是研发创新抗癌药物,为具有高度未满足医疗需求的患者提供新的治疗选择。浩鼎的研发核心聚焦于新型抗体-药物偶联物(Antibody-Drug Conjugates, ADC),包括第一代半胱氨酸偶联 TROP2 ADC:OBI-992。通过专利 ADC 关键技术 GlycOBI®,结合 EndoSymeOBI® 和 HYPrOBI®,浩鼎已建立下一代 ADC 产品布局,包括:单抗 ADC:OBI-902(TROP2)、OBI-904(Nectin-4)双抗单药 ADC:HER2 × TROP2双抗双药 ADC:cMET × HER3为拓展 HYPrOBI® 在连接子领域的应用范围,浩鼎进一步开发新型 ThiOBI® 平台,实现不可逆的半胱氨酸偶联能力。此外,浩鼎产品线亦包含全球首创 AKR1C3 靶向小分子前药 OBI-3424,该药物可在肿瘤中过表达的醛酮还原酶(AKR1C3)作用下选择性释放强效 DNA 烷基化剂以治疗癌症。更多信息请参阅: www.obipharma.com 。GlycOBI®、EndoSymeOBI®、ThiOBI® 和 HYPrOBI® 为浩鼎注册商标。Obrion™ 与 GlycOBI DUO™ 为申请中商标。1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products媒体联系:陈祈宏 Derek Chen公共事务部 负责人 | Head of Public Affairs台灣浩鼎(OBI Pharma, Inc.)M: +886-939-797-803 | T: +886-2-2655-8799 Ext. 223derekchen@obipharma.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Indonesia’s TASPEN Fulfills Global Mandate, Delivering Full Benefits to Late Diplomat’s Family

Indonesia’s TASPEN Fulfills Global Mandate, Delivering Full Benefits to Late Diplomat’s Family

JAKARTA, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Indonesia's state-owned social security agency PT TASPEN (Persero) has reiterated its commitment to ensuring social protection for all Indonesian Civil Servants and State Officials, including those stationed abroad.President Director Taspen, Rony Hanityo (2nd left) delivers Work Accident Security Program benefits to the wife of the late Zetro Leonardo Purba, Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on Sept 1, 2025.The statement follows TASPEN's recent distribution of Work Accident Security Program (Jaminan Kecelakaan Kerja/JKK) benefits to the family of the late Zetro Leonardo Purba, a Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on September 1, 2025.TASPEN Corporate Secretary Henra expressed condolences to the bereaved family and underscored the agency's role in upholding the state's responsibility to protect civil servants serving anywhere in the world."TASPEN expresses its deepest condolences on the passing of Mr. Zetro Leonardo. The distribution of these benefits is proof that TASPEN carries out its state mandate with integrity and accountability. It is our responsibility to ensure that every civil servant's dedication — even at the farthest corners of the world — is accompanied by a sense of security for them and their families. The state's protection knows no borders," said Aprianto.As of September 30, 2025, TASPEN has provided JKK benefits to 221 heirs of Indonesian civil servants, including those serving on overseas assignments — a reflection of the government's continued commitment to the welfare of public sector workers worldwide.Comprehensive Protection for Civil Servants and FamiliesThe assistance provided to Mr. Purba's family includes Old-Age Savings Program (Tabungan Hari Tua/THT) and Work Accident Security Program benefits, such as Death Benefits/Bereavement Benefits, Death Compensation, and Funeral Benefit. In addition, Scholarship Benefit has been granted for two of his children to support their continued education — part of TASPEN's broader effort to ensure long-term family welfare.The Work Accident Security Program (JKK) forms part of Indonesia's national social protection framework for civil servants and state officials who experience work-related accidents, occupational illnesses, or death while performing state duties — whether domestically or abroad.Four Key Programs Supporting Civil ServantsTASPEN manages four major programs designed to create an integrated and sustainable social security system for civil servants:1. Old-Age Savings Program (THT): A savings and protection plan for employees nearing retirement or their families in case of death before retirement.2. Pension Program: Guarantees a regular post-retirement income as recognition of civil servants' long-term service.3. Work Accident Security Program (JKK): Covers the risk of workplace injuries, illnesses, or death occurring in the line of duty, including while serving abroad.4. Death Security Program (Jaminan Kematian/JKM): Provides compensation and educational scholarships for the families of civil servants who pass away from non-work-related causes.These programs establish a comprehensive social safety net that protects civil servants throughout their professional and personal lives. TASPEN's initiatives reflect the Indonesian government's principle that public service deserves lifelong protection — regardless of where it is carried out. By extending coverage beyond national boundaries, the TASPEN ensures that Indonesian civil servants serving on global missions receive the same level of welfare assurance as those at home.Through adaptive and accountable management, TASPEN continues to play a strategic role as a partner of the Indonesian government in strengthening the welfare and security of civil servants worldwide.About PT TASPEN (Persero)PT TASPEN (Persero) or the Civil Servant Savings and Insurance Fund is an Indonesian state-owned enterprise engaged in retirement savings insurance and pension funds for civil servants (ASN) and state officials. Established on April 17, 1963, PT TASPEN (Persero) plays an active role in social welfare, particularly for civil servants in Indonesia. PT TASPEN (Persero) currently offers several products and services, namely the Work Accident Security Program (JKK), Death Security Program (JKM), Old-Age Savings Program (THT), and Pension Program.PT TASPEN (Persero) is currently the First Chairman of the Asian Civil Service Pension Association (ACSPA), which is the first Association of Social Security Administrators for Civil Servants in Asia, with members consisting of Social Security Administrators for ASN from various countries in Asia, including Indonesia, South Korea, the Philippines, Thailand, and Cambodia. PT TASPEN (Persero) prioritizes the comfort and safety of its participants by implementing the digital superapp service Andal by TASPEN.For information, you can contact the Call Center at 1500919, visit the official website www.taspen.co.id, tcare.taspen.co.id, and all official social media accounts of PT TASPEN (Persero). Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
SuperX AI Technology Limited任命企业科技资深领军人物黄陈宏博士为董事局主席兼CEO 加速全球AI基础设施布局

SuperX AI Technology Limited任命企业科技资深领军人物黄陈宏博士为董事局主席兼CEO 加速全球AI基础设施布局

新加坡, 2025年11月17日 - (亚太商訊) - SuperX AI Technology Limited (纳斯达克: SUPX)(简称"SuperX"或"公司"),一家全栈式 AI 基础设施解决方案提供商,今日宣布任命黄陈宏博士为公司董事局主席、执行董事兼首席执行官,该任命自 2025 年 12月 1 日起生效。随着全球 AI 计算需求的持续增长,企业对集成化、高能效的基础设施解决方案需求激增。此次任命正值SuperX发展的重要阶段,公司将继续推进其全球扩张工作。董事会相信,经验丰富的领导层将支持公司执行其战略优先事项的能力。这一战略性任命标志着SuperX在成为全球人工智能基础设施领导者的征程中迈出了关键一步。此举不仅为公司带来了黄博士数十年的高管领导经验,同时也将加强其经营管理和公司治理。此次委任旨在通过黄博士卓越的领导力和深厚的行业积淀,加速推进公司构建全球化的全栈式模块化AI工厂的宏伟蓝图。在此之前,公司也于2025年11月11日任命Frank Han为执行董事,以及Roy Rong为独立董事。Frank Han曾任黑石集团资深合伙人,此前还曾在凯雷集团美国收购部、高盛亚洲特殊情况部和麦肯锡公司任职。Roy Rong目前担任TikTok及全球职能部门的财务业务合作伙伴负责人。他曾担任魔古科技(纽约证券交易所代码:MOGU)和车车集团(纳斯达克代码:CCG)的独立董事和审计委员会主席,并在Yixia Technology Co., Ltd.、Quixey Inc.、UC Web、乡村基(中国)餐饮管理有限公司(纽约证券交易所代码:CCSC)、谷歌、Soletron和Sibel Systems等公司担任首席财务官和财务管理职务。黄陈宏博士:引领SuperX开启AI基础设施新篇章的资深领航者黄陈宏博士是一位资深的企业技术领袖,拥有三十年成功领导并扩展跨国公司各类主营业务的辉煌经验。他的加入,是SuperX为提升战略执行、实现全球扩张而做出的极具前瞻性的决策,与SuperX构建端到端AI基础设施的使命深度契合。规模化复杂技术运营的卓越专长:黄博士曾担任SAP全球执行副总裁兼大中华区总裁,以及戴尔大中华区董事长兼总裁,成功管理和扩展了全球最复杂的企业技术业务。该经验使他深谙如何在全球范围内构建和管理高度复杂的运营体系。SuperX致力于打造一个覆盖全球的"AI工厂"蓝图,这一前所未有的挑战,正是黄博士多年积累的规模化运营经验和卓越领导力的用武之地。他也将引领SuperX在全球范围内高效、有序地推进AI基础设施的部署,期望为公司带来可预见的规模效应和增长回报。深厚的数据中心基础设施与电源方案专业背景: 在担任施耐德电气旗下APC大中华区总裁期间,黄博士积累了数据中心电力和冷却基础设施领域的关键实践经验和专业知识。这对于SuperX而言至关重要,因为高性能AI的基石正是稳定、高效的基础设施,特别是其专有的液冷解决方案。黄博士的专业背景将帮助SuperX优化其核心技术,确保为客户提供绿色、高性价比的计算能力。核心网络与技术能力的坚实根基: 黄博士早期在Tellabs和北电网络(Nortel Networks)的任职经历,赋予了他深厚的网络技术功底和管理经验。这将为他领导SuperX这家植根于"硬件+软件+服务"全栈模式的公司奠定坚实基础,确保公司在技术创新和整合方面保持优势。黄陈宏博士表示: "我非常荣幸能在AI的黄金时代领导SuperX。当前市场需求正迅速从单一组件转向集成化、端到端且能快速大规模部署的解决方案——我们将其定义为‘AI工厂’。SuperX拥有清晰的战略愿景和具有颠覆性的集成技术。我的首要任务是聚焦运营执行,加速我们全栈AI基础设施的全球部署,将SuperX打造成为AI基础建设领域当之无愧的全球领导者,为股东创造长期可持续的价值。"黄陈宏博士简介黄陈宏博士是一位经验丰富的技术高管,拥有超过30年的全球企业软件、云计算和IT基础设施公司领导经验。自2025年4月起,他担任中国领先的企业软件公司用友的董事会成员,此前于2025年1月至3月担任该公司总裁。在此之前,黄博士于2021年8月至2024年12月担任SAP全球执行副总裁兼大中华区总裁,期间他负责推动云业务收入的显著增长。2014年10月至2021年8月,他担任戴尔大中华区董事长兼总裁,指导戴尔在该地区的业务拓展,并领导了EMC收购后的整合工作。黄博士早年曾在施耐德电气旗下的APC公司、泰乐公司和北电网络公司担任高级领导职务,包括APC大中华区总裁、珠海Uniflair董事长、泰乐中国区总裁以及北电网络中国区运营商销售总裁。黄博士拥有德克萨斯农工大学电气工程博士学位、复旦大学硕士学位和复旦大学物理学学士学位。黄博士是美国公民。关于SuperX AI Technology Limited(纳斯达克代码:SUPX)SuperX AI Technology Limited 是一家人工智能基础设施解决方案提供商,为人工智能数据中心提供全面的产品组合,包括专有硬件、先进软件以及端到端的服务。公司的服务涵盖先进的解决方案设计与规划、高性价比的基础设施产品集成,以及端到端的运营与维护。其核心产品包括高性能AI服务器、800伏直流(800VDC)解决方案、高密度液冷解决方案,以及AI云和AI智慧体。公司总部位于新加坡,为全球的机构客户提供服务,包括大型企业、研究机构、云及边缘计算部署等。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
15th Asian Logistics, Maritime and Aviation Conference opens today

15th Asian Logistics, Maritime and Aviation Conference opens today

- The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC) opened today under the theme “Collaboration and Growth in the New Trade Landscape”- The event brings together over 80 heavyweight speakers to explore industry trends and opportunities, driving high-quality development in logistics and supply chain management- New thematic sessions spotlight the Middle East and Central Asia markets, with speakers sharing the latest developments and future opportunities, analysing key strategies and investment directions- John Lee, Chief Executive of the HKSAR, and Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, attended the Special Address session on the first day of the conference. Their participation aims to deepen international exchange and cooperation, helping to further enhance Hong Kong’s position as an international shipping and aviation hub and its roles as a “superconnector” and “super value-adder”.HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC), opened today (17 November) and runs for two days at the Hong Kong Convention and Exhibition Centre. Under the theme “Collaboration and Growth in the New Trade Landscape”, the conference aligns with recommendations in the 15th Five-Year Plan to enhance Hong Kong’s status as an international shipping centre, and policies laid out in the Policy Address to strengthen the development of the shipping, aviation and logistics sectors in the city. As the industry’s annual flagship event, the two-day conference gathers over 80 distinguished speakers, including government officials and industry leaders, to discuss trends and opportunities and promote high-quality development in logistics and supply chain management.John Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special Address. In addition, this year’s ALMAC invited Central Asian official Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, to also deliver a Special Address.John Lee said: “The conference theme this year, ‘Collaboration and Growth in the New Trade Landscape’, is a timely response to rising geopolitical tensions and the volatile global trade policies, which present considerable challenges for our maritime, aviation and logistics industries, from route planning and shipping fleet deployment to inventory and warehouse management. Nevertheless, as the Chinese saying goes, ‘where there are challenges, there are opportunities’. Geopolitical risks can be overcome by market diversification. Increased costs related to supply chain concerns can be offset, at least partially, by technology-enabled efficiencies.”Mr Lee also shared: “I am particularly pleased to announce that Hong Kong has established Partner Port relationships with Guangxi port and Dalian port in the Chinese Mainland, and Port San Antonio in Chile. These ports are of strategic importance, and true to our character and policy priorities. As an international maritime centre, we connect the Chinese Mainland with the world and seek partners who support an open, international trade order.”In her welcome remarks, Sophia Chong, Executive Director of the HKTDC, said: “Now is the perfect time to embrace new possibilities, as trade networks and supply chains around the world undergo a sweeping transformation. The ever-changing trade polices of major economies continue to keep business agile. At the same time, the world is being rapidly reshaped by technological advances – particularly the digitalisation of trade – and a growing industry-wide commitment to sustainability. Hong Kong, as a major hub for aviation, shipping, logistics and supply chain management, is at the forefront of these changes. The HKTDC remains committed to leveraging the city’s unique strengths to help businesses establish resilient and sustainable supply chains, while reinforcing Hong Kong’s role as a superconnector and super value-adder.”Strengthening Hong Kong’s logistics hub role and promoting regional cooperationRecommendations in the 15th Five-Year Plan to support the consolidation and enhancement of Hong Kong’s status as an international shipping centre carry profound strategic significance. The HKTDC will continue to deepen Hong Kong’s role as an international exchange platform, facilitating connections and substantive cooperation between local and overseas industries, assisting enterprises in “going global”, helping to expand their businesses in global markets, and enhancing their competitiveness. A key focus is promoting trade linkages and actively encouraging enterprises to leverage the HKTDC’s trade platforms and events to achieve greater cooperation across industries. This year’s ALMAC continues to feature business-matching sessions, connecting shippers with service providers to foster regional partnerships and drive industry growth.ALMAC this year features exhibition zones dedicated to aviation, the low-altitude economy, technology, supply chain management and logistics services as well as maritime and port services. Over 90 exhibitors are showcasing the latest leading logistics and supply chain solutions. Notably, the Low-altitude Economy zone makes its debut at ALMAC, with enterprises from the Regulatory Sandbox pilot projects – including SF Express (Hong Kong) and Esri China (Hong Kong) Limited –demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles (UAVs) and urban air mobility (UAM), promoting awareness of the latest innovations and applications in this fast-rising sector.Three key trends in focus; unlocking opportunities in the Middle East and Central AsiaThis year’s ALMAC focuses on three key trends: supply chain diversification, sustainability and green energy and innovation and technology, highlighting Hong Kong’s critical role in global connectivity.On the first day, the key session “Insights into a New Era of Global Trade: Driving Business Growth” will feature international industry leaders from SEKO Logistics, GEODIS, and Mattel who will explore the challenges and opportunities arising from changes in trade policies and economic fragmentation. Newly launched thematic sessions will focus on the potential of the Middle Eastern and Central Asian markets. In the Middle East Session, representatives from Etihad Airways, DP World Logistics and the Qatar Free Zones Authority will share insights on logistics innovation and investment strategies. The Central Asia Session will engage representatives from QazTrade Center for Trade Policy Development, JSC, under the Ministry of Trade and Integration of the Republic of Kazakhstan, Shyngar Trans Logistics Company, the Organisation for Economic Co-Operation and Development and PTC. The discussion will address regional supply chain development and the advantages of multimodal transport.Low-altitude economy and smart ports: reshaping the air and maritime transport landscapeIn the first-day session “The Engine of Low-altitude Economy: How Cargo Drones Are Revolutionising the Future of Air Logistics”, Manal Habib, CEO and Founder, MightyFly; Bobby Healy, CEO and Founder, Manna; Kenny Lau, Chief Technology Officer, SF Express (Hong Kong) Limited; Ryan Walsh, Founder and CEO, Valqari; and Andrea Wu, CEO, Urban-Air Port Ltd, shared the latest breakthroughs in drone freight design, automation and AI-driven logistics systems. Meanwhile, the Low-altitude Economy zone at the conference is showcasing drones and related applications, allowing participants to experience first hand the future of air transport and explore the potential of low-altitude economy innovations in the logistics sector.In addition, the Port Community System X LSCM Maritime Summit 2025 will focus on the future development of smart ports and smart trade. The summit will explore how applying the Port Community System (PCS) can significantly enhance operational efficiency and supply chain visibility through cutting-edge technologies such as AI, blockchain and the Internet of Things. It will also showcase Hong Kong’s unique advantages as an international shipping centre and a hub for smart trade. Conference and workshops support enterprises’ green transformationA first-day workshop, “Sustainable Finance: Navigating a Sustainable Future across Logistics, Shipping, and Aviation Industries”, focused on how ESG (environmental, social and governance) is reshaping operational models and development directions in the logistics, maritime and aviation sectors. Patrick Lau, Deputy Executive Director of the HKTDC, gave the Opening Address at the workshop, followed by industry experts including KT Ting, Chief Operating Officer, Hong Kong Quality Assurance Agency; Calvin Chung, Director, Chimbusco Pan Nation; Wai Yeung Tam, Senior Finance Manager, SF REIT Asset Management Limited; and Eric Liu, Chief Executive, Cathay United Bank Hong Kong Branch. They discussed challenges and opportunities in the industry’s green transformation and addressed the important role of sustainable finance to support enterprises in the transition.As the world strives towards net-zero emissions, Hong Kong is committed to developing as a green maritime centre. The recent Policy Address proposes establishing Hong Kong as a green marine fuel bunkering centre, focusing on green methanol, green ammonia and hydrogen. A session titled “Green Energy Forum: Fuels, Freight, and the Road to Net Zero” will be held tomorrow (18 November) to share pathways, challenges and opportunities for a more sustainable and low-carbon future. Speakers include Essam Al Sheibany, Vice President Sustainability, Asyad Group; Tryggvi Thor Herbertsson, Head of Hydrogen Strategy and Partnership, Qair Group; James Laybourn, Regional Segment Director, APAC, DNV Energy Systems; and Wu Yi, Deputy General Manager, Kunlun Energy Co., Ltd.ALMAC offers a rich and diverse programme for participants, with tomorrow’s highlighted sessions, including the Hong Kong Authorized Economic Operator (AEO) Programme, the Supply Chain Management and Logistics Panel, “Logtech Forum: Stay Ahead in the Next Wave of Supply Chain Innovation”, and the Youth Empowerment Workshop. Representatives from companies such as HP, Reckitt, DHL Express, LALAMOVE and Procter & Gamble will share valuable insights and practical skills, helping participants stay ahead of the latest industry developments.The 15th Asian Logistics, Maritime and Aviation ConferenceDate17 and 18 November 2025 (Monday and Tuesday)VenueHall 3FG, HKCECWebsitesALMAC: https://almac.hktdc.com/conference/almac/enProgramme: https://almac.hktdc.com/conference/almac/en/programmeSpeaker list: https://almac.hktdc.com/conference/almac/en/speakerPhoto download: https://bit.ly/4ojiKsFThe 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the HKSAR Government and the HKTDC, opened today. Under the theme “Collaboration and Growth in the New Trade Landscape”, the event brings over 80 heavyweight speakers to explore industry trends and opportunitiesJohn Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special AddressSophia Chong, Executive Director of the HKTDC, delivered welcome remarks at the Opening SessionBusiness-matching sessions at ALMAC are connecting shippers with service providers to foster regional partnerships and drive industry growthThe Low-altitude Economy zone made its debut at this year’s ALMAC Exhibition, demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles and urban air mobilityThe session titled “Steering Business Growth in a New Era of Global Trade” explored the ripple effects of evolving trade policies and the impact of rising economic fragmentationIn the session “Tapping the Middle East: Logistics, Innovation & Trade Potentials”, industry leaders from the Middle East shared the huge opportunities and transformation potential in logistics and supply chainsMedia enquiriesYuan Tung Financial Relations:Louise SongTel: (852) 3428 5690Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Johnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Focus Graphite Commissions WSP to Complete Air Dispersion Modelling and Dust Management Plan at Lac Knife

Focus Graphite Commissions WSP to Complete Air Dispersion Modelling and Dust Management Plan at Lac Knife

The updated study incorporates redesigned dry-stack tailings system engineered to eliminate acid mine drainage and is one of the final ESIA reports.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - November 17, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects, is pleased to announce that it has commissioned an updated Air Dispersion Modelling and Dust Management Study (the "Study") for its 100%-wholly owned Lac Knife Project (the "Project") in Quebec. This work represents one of the final environmental studies required to complete the Environmental and Social Impact Assessment ("ESIA") and advance the Project toward mine-permitting readiness.The Study will be led by WSP Canada Inc. ("WSP"), a world-leading Montreal-based global engineering, environmental, and professional-services consultancy, and will be conducted under the supervision and management of IOS Geosciences Inc. ("IOS"), the Company's geological consultant and general contractor for the Project. WSP includes the former Woods Engineering, which participated in the 2019 preliminary design of the dry-stack tailings storage facility ("TSF"), as well as Golder Inc., which conducted the original 2014 Study.The Study will evaluate the potential airborne dispersion of dust and gases associated with mining operations, including:wind-driven erosion from the TSF,emissions generated by blasting activities, andtraffic-related dust along the 7-kilometre access road linking Lac Knife to Highway 389.This updated modelling replaces the earlier 2014 study to reflect the re-engineered dry-stack tailings design, developed as part of the 2021 Feasibility Study (the "Feasibility") update. The redesign eliminates the former wet-pond configuration and instead utilizes dolomitic marble to amend and encapsulate tailings, thereby preventing acid mind drainage ("AMD") and metal leaching. This new TSF concept was considered material enough to necessitate remodelling of the areal dispersion.The current program directly addresses follow-up questions from Quebec's Ministry of Sustainable Development, Environment, and the Fight Against Climate Change ("MDDELCC"), issued during its review of the Company's 2014 ESIA submission. Results from the Study are expected by February 2026, aligning with the planned submission of the final revised ESIA."The completion of the air dispersion modelling and dust management plan marks one of the last major technical steps in our environmental review process," said Dean Hanisch, Chief Executive Officer of Focus Graphite. "We are now systematically finalizing outstanding ESIA components to move Lac Knife toward the permitting stage. Each of these studies reflects our ongoing commitment to advance the Project responsibly."Qualified PersonThe technical content disclosed in this news release was reviewed and approved by Rejean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.About WSP Canada Inc.WSP Canada Inc. is a Canadian subsidiary of WSP Global Inc., one of the world's leading professional-services firms. Headquartered in Montreal, Quebec, WSP provides multidisciplinary engineering, environmental, and consulting services across the infrastructure, energy, mining, transportation, and built-environment sectors. With thousands of professionals across Canada and internationally, WSP delivers technical excellence and sustainable solutions supporting clients through every stage of project development.For more information on WSP Canada Inc. please visit https://www.wsp.com/en-ca/ About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Focus Graphite's flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Focus Graphite's Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, they go beyond mining – we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Focus Graphite's commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals – reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comLinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated timing, scope, and results of the Air Dispersion Modelling and Dust Management Study (the "Study") at the Lac Knife Project; the completion of the Company's Environmental and Social Impact Assessment ("ESIA") and related technical studies, including hydrogeological and tailings dam analyses; the expected timing of regulatory submissions and approvals; the potential for the Project to achieve mine-permitting readiness; and the advancement of the Lac Knife Project toward development. Forward-looking information also includes statements regarding the Company's expectations concerning the effectiveness of the redesigned dry-stack tailings storage facility, the ability to meet Québec's environmental and regulatory standards, the anticipated role of the Lac Knife and Lac Tetepisca projects within Canada's Critical Minerals Strategy, and the Company's capacity to secure the financing and partnerships required to advance these projects responsibly and sustainably.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274738 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
卓智医院与香港养和医院携手推出优质跨境医疗礼宾服务

卓智医院与香港养和医院携手推出优质跨境医疗礼宾服务

香港, 2025年11月17日 - (亚太商訊) - 位于新濠影汇的开创性度假村医疗设施卓智医院(iRad),今日宣布与香港养和医院签订合作协议。此次合作推出全方位跨境医疗礼宾服务,强化澳门政府「1+4」产业适度多元发展框架,助力澳门成为新兴医疗旅游目的地。这项战略联盟实现两地医疗服务的无缝连接,透过iRad的医疗礼宾平台为患者提供更多专科医疗资源。 结合香港养和医院103年深厚的综合医疗传承与iRad逾20年的专业医疗经验及度假村融合医疗模式,此伙伴关系建立起覆盖珠江三角洲地区前所未有的医疗网络。医疗礼宾计划促进综合护理协调、跨机构高效排程,以及运用双方机构资源制定的个人化治疗方案。这种全面的方式确保护理服务的无缝衔接,为区内寻求医疗服务的患者带来更佳的临床效果。黑桃资本创办人及新濠主席兼行政总裁何猷龙先生表示:「iRad与香港养和医院的合作展现我们推进澳门『1+4』产业转型议程的承诺,在两地之间创建重要的医疗连结,丰富新濠影汇的健康旅游内容,同时扩展大湾区社区的医疗选择。」养和医疗集团营运总监李维文先生表示:「与iRad合作反映我们无界限医疗的愿景,为两地市场的患者带来卓越价值,为大湾区发展新思路,进一步深化湾区内各领域间合作创新。」 图片说明:(左起)香港养和医院业务拓展主管陈威旭先生、卓智医院创办人兼主席颜文煌医生、养和医疗集团营运总监李维文先生、黑桃资本创办人及新濠主席兼行政总裁何猷龙先生、黑桃资本行政总裁及卓智医院荣誉主席谭志伟先生、香港养和医院副院长刘楚钊医生,以及卓智医院首席执行官黄建丰先生,共同庆祝卓智医院与香港养和医院达成战略伙伴关系。 关于养和医疗集团养和医疗集团于 2017 年 9 月正式启动,旗下成员分别有养和医院、养和医健、养和东区医疗中心及养和癌症中心。养和医疗集团以全方位策略,透过优质临床医疗服务、医学教育和科研,以及公众健康教育,推动公共卫生及医学发展,致力为患者提供全人关顾的优质医疗及护理服务。养和医院是养和医疗集团之重要成员,成立于 1922 年,为香港主要私营医院之一,以「优质服务‧卓越护理」为宗旨,致力服务大众,并积极推动医学教育和研究。关于养和医疗集团,请浏览www.hksh.com.关于卓智医疗集团—香港最大的磁力共振诊断服务供应商卓智医疗成立于2005年,是香港放射诊断领域规模领先的医疗集团。黑桃资本自2021年起成为卓智医疗的控股股东。截至2024年,卓智医疗集团凭借营业收入及磁力共振扫描仪数量,成为香港规模最大的磁力共振诊断服务供应商。集团致力提供优质的医学扫描诊断服务及卓越的病人护理,拥有广泛且稳固的客户基础,包括香港特别行政区政府、知名保险公司、具影响力的医疗团体、企业、私人医生和非政府组织。与此同时,卓智医院作为澳门综合度假村内首家且规模最大的私人医学影像与检查服务供应商,使卓智集团成为全球首个为综合度假村产业提供全面私人影像及检查服务(包括磁力共振与电脑断层扫描服务)的医学影像集团。传媒垂询:纵横财经公关顾问有限公司李惠儿电话:+852 2864 4834电邮:vicky.lee@sprg.com.hk 欧阳蔚雯电话:+852 2114 4913电邮:iris.auyeung@sprg.com.hk网址:www.sprg.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
‘iRad Hospital’ and ‘Hong Kong Sanatorium & Hospital’ Partner to Launch Premium Cross-Border Medical Concierge Services

‘iRad Hospital’ and ‘Hong Kong Sanatorium & Hospital’ Partner to Launch Premium Cross-Border Medical Concierge Services

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – iRad Hospital, the pioneering resort medical facility located at Studio City, today announced the signing of a cooperation agreement with Hong Kong Sanatorium & Hospital. This partnership launches comprehensive cross-border medical concierge services, reinforcing the Macau government's "1+4" moderate economic diversification framework and supporting Macau's emergence as a medical tourism destination.This strategic alliance enables seamless connectivity of medical services between the two regions, providing patients with access to expanded specialty medical resources through iRad's medical concierge platform.Combining Hong Kong Sanatorium & Hospital's 103-year legacy of comprehensive medical excellence with iRad's over 20 years of professional medical experience and resort-integrated healthcare model, this partnership establishes an unprecedented healthcare network covering the Pearl River Delta region.The medical concierge program facilitates integrated care coordination, efficient cross-institutional scheduling, and personalized treatment plans utilizing resources from both institutions. This comprehensive approach ensures seamless continuity of care, delivering better clinical outcomes for patients seeking medical services in the region.Mr. Lawrence Ho, Founder of Black Spade Capital and Chairman & CEO of Melco, stated, "The collaboration between iRad and Hong Kong Sanatorium & Hospital demonstrates our commitment to advancing Macau's '1+4' industrial transformation agenda, creating vital healthcare connections between the two regions, enriching Studio City's health tourism offerings while expanding healthcare options for the Greater Bay Area community."Mr. Wyman Li, Chief Operating Officer of HKSH Medical Group, remarked, "Partnering with iRad reflects our vision of borderless healthcare, bringing exceptional value to patients in both markets, developing new approaches for the Greater Bay Area, and further deepening collaborative innovation across various sectors within the region."Photo caption: (From left to right) HKSH Head of Business Development Mr. Wei-Hsu Chen, iRad Hospital Founder & Chairman Dr. Matthew Ngan, HKSH Medical Group Chief Operating Officer Mr. Wyman Li, Black Spade Capital Founder and Melco Chairman & CEO Mr. Lawrence Ho, Black Spade Capital CEO and iRad Hospital Honorary Chairman Mr. Dennis Tam, HKSH Assistant Medical Superintendent Dr. Lau Chor Chiu, and iRad Hospital CEO Mr. Kin Wong celebrate the strategic partnership between iRad Hospital and Hong Kong Sanatorium & Hospital.About HKSH Medical GroupOfficially launched in September 2017, HKSH Medical Group promotes public health and advanced medicine through a multi-faceted, coordinated approach across clinical services, medical education, scientific research and public health education. Members of the Group, including Hong Kong Sanatorium & Hospital, HKSH Healthcare and HKSH Eastern Medical Centre, are dedicated to offering top-quality holistic care to patients, upholding the motto “Quality in Service, Excellence in Care.”Hong Kong Sanatorium & Hospital is a key member of HKSH Medical Group. Established in 1922, it is one of the leading private hospitals in Hong Kong. Living up to its motto of “Quality in Service Excellence in Care,” the Hospital is committed to serving the public as well as promoting medical education and research.For more information about HKSH Medical Group, please visit www.hksh.com.About iRad Medical Group—Hong Kong's Largest MRI Diagnostic Service ProviderEstablished in 2005, iRad is a trusted leader in diagnostic radiology across Hong Kong. Black Spade Capital has been iRad Medical's controlling shareholder since 2021. As at 2024, iRad was the largest MRI diagnostic services provider in Hong Kong by revenue and by the number of MRI scanners. Focused on delivering high-quality imaging services and exceptional patient care, the Group's strong and extensive client base includes the Government of the Hong Kong SAR, as well as other high-profile medical groups, corporations, private doctors and NGOs. Meanwhile, iRad Hospital is the first and largest private medical imaging and examination service provider within an integrated resort in Macau, making iRad Group the first medical imaging group in the world to offer comprehensive private imaging and examination services, including MRI and CT services, to the integrated resort industry.Media Enquiries:Strategic Financial Relations LimitedVicky LeeTel: +852 2864 4834Email: vicky.lee@sprg.com.hk Iris Au YeungTel: +852 2114 4913Email: iris.auyeung@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
PCG’s Stablecoin Settlement Pilot Demonstrates 5-Second Cross-Border Settlement Breakthrough, Fostering a New Digital Finance Ecosystem and Reinforcing Hong Kong’s Position as an International Financial Center

PCG’s Stablecoin Settlement Pilot Demonstrates 5-Second Cross-Border Settlement Breakthrough, Fostering a New Digital Finance Ecosystem and Reinforcing Hong Kong’s Position as an International Financial Center

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – Coinciding with Hong Kong FinTech Week and StartmeupHK Festival, held from November 3 to 7 featuring a series of annual events, the Payment Card Group Limited (“PCG”), a cloud-native payment processor and acquirer, demonstrated its comprehensive business strategy. On November 7, PCG presented its stablecoin settlement pilot program at the Cyberport Venture Capital Forum 2025 (CVCF), demonstrating a technological breakthrough in achieving 5-second cross-border settlement. Additionally, PCG co-organized a forum with the Hong Kong Digital Finance Association (HKDiFi) and shared industry insights on the evolving role of responsible officers. In terms of business development, PCG’s members, Yedpay and BBMSL, have partnered with Visa to launch the “China-Issued Visa Credit Card Instant Discount Program,” helping local merchants expand their mainland customer base. Meanwhile, PCG has continued to promote its “AbbyPay” POS-free digital payment solution at an exchange event with Chiyu Bank and various industry events, driving deeper integration between traditional finance and innovative technology, and demonstrating its forward-looking strategy and industry influence within the digital finance ecosystem.Showcasing stablecoin settlement pilot program at Cyberport Venture Capital Forum 2025On November 7, PCG showcased its latest projects and technological achievements at the Cyberport Venture Capital Forum 2025 (CVCF), including the stablecoin settlement pilot program and the “AbbyPay” POS-free digital payment solution. As the only payment technology company selected in the “Payment & Stablecoin” category under Cyberport’s “Blockchain & Digital Asset Pilot Subsidy Scheme,” PCG launched a stablecoin settlement pilot program with the vision of bridging traditional card payments with Web3 infrastructure. The pilot simulated an Australia-to-Hong Kong transaction using stablecoins within a controlled test environment. Compared to traditional settlement that takes 2 to 3 days and involves high FX and SWIFT costs, stablecoin settlement can be completed under 5 seconds, at 90% lower cost, with on-chain transparency. This solution enables real-time reconciliation, programmable payouts, and cross-border scalability, fully demonstrating the potential of stablecoins to enhance the payment infrastructure.Mr. Michael Hui, Regional Product Director of PCG, stated during the Cyberport’s Blockchain & Digital Asset Pilot Subsidy Scheme use case-sharing session, “With Hong Kong’s Stablecoins Ordinance now in effect, we welcome and support this forward-looking regulatory framework. Thanks to Cyberport, JETCO, our advisors, and industry partners, our pilot program has demonstrated how traditional card payments and Web3 infrastructure can truly come together, achieving stable, efficient, and compliant settlement through blockchain. Looking ahead, we will extend the pilot with merchants across various industries and continue to collaborate with banks, acquirers, and fintech companies to advance industry dialogue and scale adoption, enabling merchants to enjoy faster, more cost-effective, and transparent cross-border payment collections. We believe that with regulated stablecoins, strong compliance, and industry collaboration, Hong Kong is poised to lead the next chapter of digital settlement innovation.”Mr. Michael Hui, Regional Product Director of PCG introduces PCG’s stablecoin settlement pilot program during the Cyberport’s Blockchain & Digital Asset Pilot Subsidy Scheme use case-sharing session.Additionally, Mr. Emil Chan, Advisor of PCG, stated at the panel discussion themed “Stablecoin from a User Perspective: Unlocking New Business Opportunities”, “Stablecoins can bring revolutionary changes to cross-border payments, significantly reducing transaction fees and settlement period. They also enhance financial inclusion, enabling anyone with a smartphone to safely and efficiently access the global market. For merchants, the advantages of stablecoin adoption such as lower fees, instant settlement, and no chargebacks for fraud prevention, can help improve cash flow and attract new customers.”During the panel discussion themed “Stablecoin from a User Perspective: Unlocking New Business Opportunities,” Mr. Emil Chan, Advisor of PCG shares how stablecoins can empower merchants and drive industry transformation.Co-hosting “The New Frontier: ROs as Catalysts for Digital Finance Ecosystems” Forum with Hong Kong Digital Finance AssociationOn the same day, PCG and the Hong Kong Digital Finance Association (HKDiFi) co-hosted an official side event of Hong Kong FinTech Week 2025, “The New Frontier: ROs as Catalysts for Digital Finance Ecosystems” Forum, exploring the new role of responsible officers (ROs) in driving business growth in an increasingly regulated environment. Prof. Emil Chan, Advisor of PCG, and Chairman of the Association of Cloud and Mobile Computing Professionals, remarked, "During PCG's stablecoin settlement research and development process, we witnessed a transformation in the role of ROs. They have evolved from mere compliance gatekeepers into key forces driving innovation. They proactively seek new avenues for innovation, establish frameworks for risk management, build trust with relevant institutions, and set the stage for project success. This shift demonstrates that ROs play a pivotal role in driving success for traditional finance in the digital era."At the Forum, Prof. Emil Chan, Advisor of PCG, and Chairman of the Association of Cloud and Mobile Computing Professionals, Dr. Kenny Siu, Training Director of ESG Academy, Dr. Raymond Chan, Vice Chairman of HKDiFi, and Dr. Hermann Lui, Program Director of Investopedia Institute of Hong Kong, analyze how ROs can redefine their roles to drive business growth.Dialogue with Chiyu Bank senior executives on Hong Kong's digital finance outlookOn October 23, PCG was honored to be invited by the Hong Kong Productivity Council (HKPC) to jointly host senior executives from Chiyu Bank as part of their executive development program centered on “Leadership in Transformation.” Mr. Emil Chan, Advisor of PCG, shared valuable insights on “Opportunities and Challenges in Hong Kong’s Digital Financial Market.” Additionally, PCG team introduced the latest “AbbyPay” POS-free digital payment solution, demonstrating its innovative breakthrough in payment technology. During the event, both parties not only explored the evolving payments landscape in Hong Kong, but also fostered in-depth exchanges between traditional banking expertise and fintech innovation through cross-industry dialogues, driving continuous industry innovation.PCG team engages in a dialogue with Chiyu Bank senior executives to explore the future of digital finance in Hong Kong.Partnering with Visa to help local merchants expand mainland customer baseRecently, PCG members, Yedpay and BBMSL, have partnered with Visa to launch the "China-Issued Visa Credit Card Instant Discount Program." From now until December 31, 2025, China Construction Bank Visa cardholders can enjoy an 8% instant discount on purchases of HK$500 or more at designated stores. Through this initiative, Yedpay and BBMSL aim to help Hong Kong merchants capitalize on the peak shopping season, precisely target high-quality mainland customer segments, and further expand into the mainland market.Yedpay and BBMSL, in partnership with Visa, launch the “China-Issued Visa Credit Card Instant Discount Program” to help Hong Kong merchants capitalize on the peak shopping season and expand their reach into the mainland market."AbbyPay" POS-free digital payment solution receives widespread industry recognitionSince its launch in September, PCG has actively showcased its innovative "AbbyPay" POS-free digital payment solution at various events. In October, PCG introduced "AbbyPay" to investors, industry leaders, and retail technology professionals at the Hong Kong Retail Technology Industry Association's 22nd Anniversary Annual Dinner and the Investment Projects and Talent Matching Fair of the 9th Global Greater Bay Area Sustainable Development Economic and Trade Summit, highlighting how its SoftPOS technology helps eliminate traditional hardware and provide a more convenient and secure payment solution. The enthusiastic response and strong endorsement from participants underscored the solution’s innovative qualities and practical benefits, reinforcing "AbbyPay's" potential in driving industry digital transformation.PCG introduces "AbbyPay" POS-free digital payment solution at the Hong Kong Retail Technology Industry Association's 22nd Anniversary Annual Dinner and the 9th Global Greater Bay Area Sustainable Development Economic and Trade Summit, receiving widespread industry recognition.About The Payment Cards GroupThe Payment Cards Group Limited (“PCG”) is an innovative and leading payment technology company with operations in Hong Kong, Singapore, and the Asia-Pacific region. Established in 2016, PCG has become an acquirer with principal memberships in all major card schemes and e-wallet networks. Yedpay, a member of PCG, has firmly established itself as a digital payment acceptance business in Hong Kong. Meanwhile, A3A, another member of PCG, has developed a cloud-native payment processing platform that operates through RESTful APIs, significantly reducing costs and streamlining complex processes while providing users with real-time transaction data and insights. Furthermore, BBMSL, a core member of PCG, is a payment facilitator, dedicated to offering comprehensive digital payment solutions to Hong Kong’s small and medium-sized enterprises. As an acquiring processor, PCG serves as the backbone infrastructure of the entire payment industry by its Asia’s 1st cloud-based processing and settlement platform. Rooted in Hong Kong with a global vison, PCG seeks to empower merchants with cutting-edge payment technology solutions and drive high-quality development in the global payment ecosystem.For media enquiries, please contact:AJA (IR & Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Unitree IPO Marks Shoucheng’s Shift From Growth to Robot Application

Unitree IPO Marks Shoucheng’s Shift From Growth to Robot Application

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – In the context of rapid evolution in the robotics industry, Shoucheng Holdings (0697.HK) is gradually transforming from a traditional infrastructure operator into a new platform company with technological attributes. Its newly released 2025 third-quarter financial report not only demonstrates the company’s solid operating fundamentals, but also clearly conveys its strategic path in the robotics industry chain—from “investment layout” toward “application implementation,” gradually building sustainable long-term growth capability.I. Maintaining High-Speed Growth, with Operating Resilience Further EnhancedThe third-quarter report shows that Shoucheng Holdings’ revenue increased 30% year-on-year to HKD 1.215 billion, while net profit attributable to shareholders rose 22% year-on-year to HKD 488 million. The asset operation business continued to expand, and the asset circulation business maintained high-yield contributions, together forming a stable and predictable operating base for the company.Cash and financial assets reached HKD 8.55 billion, while the asset-liability ratio stood at only 31.5%. The company’s financial structure remains sound, providing sufficient “margin of safety” for new investments and business incubation in robotics. On this steady operating foundation, the company announced a HKD 1 billion share repurchase plan over the next three years, with management demonstrating confidence in corporate value through long-term capital commitment.II. Robotics Enter a Dual-Track Stage of “Investment Deepening + Application Validation”Unlike many market participants who remain at the stage of technology demonstrations or laboratory prototypes, Shoucheng Holdings’ robotics layout already shows a “two-line advancement” pattern:One line upward, deepening investment along the industry chain; One line downward, deploying real application scenarios.(1) Investment deepening: Key industry chain enterprises enter their capital-market sprintThrough its industrial funds, Shoucheng Holdings is investing in humanoid robots, embodied intelligence, flying robots, intelligent perception and other directions, focusing resources on globally competitive enterprises. Recent developments include:Unitree Robotics completing IPO counseling, expected to become the first humanoid robot stock in the A-share market;Yunshengchu completing its shareholding restructuring and officially entering the IPO preparation stage;Multiple enterprises expected to be eligible for listing in 2026.The capital-market progress of these enterprises will bring structural returns to Shoucheng Holdings’ equity investment business and open new space for future profit growth.(2) Application validation: Building a “scenario network” for large-scale robot deploymentTo open the path from “technology” to “commercialization,” Shoucheng Holdings has not stopped at the investment level but has simultaneously built consumer-side and urban-side scenario networks. Examples include:The “Taozhu New Craft Bureau” robot technology experience stores launched in Beijing, Chengdu, and airport landmarks, enabling robots to be “visible, usable, and purchasable”;The “Shoucheng W” robot livestreaming studio, which enhances online reach through real-time demonstrations and consumer conversion models;Pilot deployments of automatic charging robots, surgical robots, and educational robots in education, healthcare, and cultural-tourism scenes.This dual-track structure—investment-driven and scenario-driven—allows Shoucheng to form early-stage resource barriers in “data, users, and demand,” becoming a key foundation for long-term expansion in the robotics sector.III. From High-Speed Growth Toward Long-Term Expansion: 2026 as the Key Inflection PointShoucheng Holdings is entering a critical stage of transitioning from “performance growth” to a “growth logic” model.On the financial side, stable asset operations provide a sufficient safety cushion;On the industrial side, investments, scenario deployments, and capital-market progress in robotics are forming a reinforcing cycle.As Unitree Robotics, Yunshengchu and other core enterprises enter the listing channel—combined with the nationwide rollout of experience stores, commercialization of autonomous charging robots, and expanding humanoid robot applications—the company’s robotics business is expected to enter a “quantifiable contribution phase” in 2026.In other words, over the past two years, Shoucheng Holdings has focused on building “infrastructure,” while in the coming years, it will begin to demonstrate “long-term growth attributes.”Based on a foundation of solid financials and forward-looking industrial layout, Shoucheng Holdings is gradually forming a dual-engine model of “robotics investment + application.” As the industry approaches the window of scenario scale-up, the company is already positioned strategically. High-speed growth is the present; long-term growth is the direction. For Shoucheng Holdings, 2026 may only mark the beginning of a new stage. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
宇树科技IPO加速 从高速增长到长期成长:首程控股的机器人投资+应用逻辑

宇树科技IPO加速 从高速增长到长期成长:首程控股的机器人投资+应用逻辑

香港, 2025年11月17日 - (亚太商訊) - 在机器人产业快速演进的当下,首程控股(0697.HK)正在从传统基础设施运营商,逐步转型为具备科技属性的新型平台公司。其最新发布的2025年第三季度财报,不仅展现了公司稳健的经营基本面,也清晰传递出其在机器人产业链上的战略路径——从"投资布局"迈向"应用落地",并逐步构建可持续的长期成长能力。一、业绩保持高速增长,经营韧性进一步增强三季报显示,首程控股收入同比增长30%至12.15亿港元,归母净利润同比提升22%至4.88亿港元。资产运营业务持续扩张,资产融通业务保持高收益贡献,合计形成公司稳定、可预期的经营底盘。现金与理财资产规模达到85亿港元,资产负债率仅31.5%,财务结构稳健,这为公司进入机器人领域的新投资与新业务孵化提供了足够的"安全边际"。在稳健经营基础上,公司宣布未来三年实施10亿港元股份回购,管理层通过长期资金承诺进一步验证了对公司价值的信心。二、机器人进入"投资深化+应用验证"双轨阶段与大多数停留在技术展示或实验室阶段的市场参与者不同,首程控股的机器人布局已呈现"双线推进"的特征:一端向上,深耕产业链投资;一端向下,布局实际应用场景。(1)投资深化:产业链关键企业陆续进入资本化冲刺期首程控股通过旗下产业基金布局人形机器人、具身智能、飞行机器人、智能感知等方向,并将资源集中在具备全球竞争力的企业。近期进展包括:宇树科技完成IPO上市辅导,有望成为A股人形机器人第一股;云深处完成股改,正式进入上市筹备阶段;多家企业在2026年具备登陆资本市场的条件。这些企业的资本化进程,将为首程控股的股权投资业务带来结构性收益,为未来利润增长打开新增空间。(2)应用验证:构建机器人大规模落地的"场景网络"为了打通机器人从"技术"到"商业"的通路,首程控股并未止步于投资端,而是同步搭建消费和城市端的场景网络。例如:"陶朱新造局"机器人科技体验店在北京、成都及机场等多个地标落地,实现机器人"看得见、用得上、买得到";"首程W"机器人直播间以实时展示与消费转化模型,补齐线上触达能力;在教育、医疗、文旅等场景中推进自动充电机器人、手术机器人、教学机器人等落地试点。投资驱动与场景驱动的双轨结构,使首程能够在机器人产业的早期阶段形成"数据、用户、需求"三类资源壁垒,构成长线增长的重要基础。三、从高速增长迈向长期成长:2026年将成为关键分界线首程控股正经历从"业绩增长"向"成长逻辑"转变的关键阶段。财务端,公司以稳健资产运营提供足够安全垫;产业端,机器人业务的投资、应用场景、资本化进展正在形成互相强化的循环。随着宇树科技、云深处等核心企业进入上市通道,加之体验店全国布局、自动充电机器人商用化、人形机器人应用不断丰富,公司机器人业务预计将在2026年进入"可量化贡献期"。换句话说,过去两年首程控股着力构建的是"基础设施";而未来几年,将开始体现"长期成长性"。首程控股以稳健财务与产业前瞻布局为基础,逐步形成"机器人投资+应用"双轮驱动的商业模型。在行业即将迎来场景放量的窗口期,公司已处在结构性优势位置。高速增长是现状,长期成长是方向,2026年对首程控股而言,或许只是一个全新阶段的开始。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
创新实业招股进行时 铝业标杆再启新程

创新实业招股进行时 铝业标杆再启新程

香港, 2025年11月17日 - (亚太商訊) - 创新实业集团有限公司(简称“创新实业”,股份代号:02788.HK)已正式启动招股,招股时间为11月14日至11月19日,全球发售共计5亿股股份,发售价介乎每股10.18港元至10.99港元,最高集资54.95亿港元。此次招股,创新实业每手认购单位为500股,入场费约为5,550港元,11月19日截止招股,预计11月24日正式挂牌上市。中金公司与华泰国际为联席保荐人。依托区域资源优势,构筑电解铝产业链一体化生态创新实业专注于氧化铝精炼及电解铝冶炼业务,是中国铝产业链上游的核心参与者。自2012年起,创新实业持续依托内蒙古和山东两地的区域资源与产业布局优势,构建了高自给率,强互补性及协同性的电解铝产业链一体化生态系统,覆盖能源、氧化铝精炼、电解铝冶炼。据CRU报告,按2024年产量计,公司位于内蒙古霍林郭勒的电解铝冶炼厂为华北第四大电解铝生产基地,公司为中国第十二大电解铝生产商。公司位于内蒙古的子公司内蒙创源于2024年获工信部授予国家级绿色工厂荣誉。在能源环节,公司已建立自有火力发电站和发电设施,并正加快建设以绿电为主的发电站及发电设施,为生产提供低成本且稳定的电力保障。根据CRU报告,2024年公司电力自给率约为88%,且显著高于约57%同业平均水平,充分体现出其在成本控制与供应安全方面的领先优势。财务表现稳健增长 盈利能力持续增强创新实业财务基础稳健,收入与利润均保持强劲增长势头。根据招股书显示,公司总收入由2022年的人民币134.90亿元增长至2024年的人民币151.63亿元,年复合增长率约为6.0%。截至2025年5月31日止前五个月,公司录得收入人民币72.14亿元,同比上升22.6%,显示出持续增长动能。盈利能力方面,公司实现质的飞跃。净利润由2022年的人民币9.13亿元大幅跃升至2024年的人民币26.30亿元,年复合增长率超过60%。这一显著提升主要得益于成本结构优化与规模效应的释放。公司毛利率在2024年上升至28.2%,较往年水平显著改善,反映出其产业链一体化模式在成本波动周期中的稳定性与高效性。截至2025年前五个月,公司净利润为人民币8.56亿元,盈利表现依然稳健。锚定全球化布局 开启价值新篇面对国内电解铝产能逐步接近政策上限的行业格局,创新实业前瞻性地将发展视野延伸至全球市场,重点把握“一带一路”沿线国家在新能源及基础设施建设方面对铝产品的强劲需求。公司正积极推进沙特阿拉伯50万吨电解铝产业链综合项目。该项目依托沙特丰富的能源资源与低成本电力,预计投产后生产成本将低于全球平均水平,有望成为公司全球化布局的重要支撑点。根据招股书显示,本次募集资金的50%将用于拓展海外产能,包括建设一家电解铝冶炼厂及购买及安装生产设施;40%将用于建设绿色能源项目;10%将用于补充营运资金及一般公司用途。未来,创新实业将持续依托其资源禀赋和产业链协同优势,在巩固国内核心产能的同时,加快海外战略布局步伐。公司将以稳健的财务管理和卓越的运营效率,为股东与投资者创造可持续的长期价值,推动中国铝工业迈向更高质量的发展阶段。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B

DUBAI, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard.The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components."The completion of our full-scale fatigue test validates years of GA-ASI design and analysis efforts," said GA-ASI President David R. Alexander. "The first two lifetimes simulated the operation of the aircraft under normal conditions, and the third intentionally inflicted damage to the airframe's critical components to demonstrate its ability to tolerate operational damage that could occur over the lifetime of the aircraft."Testing was conducted from December 13, 2022, through October 31, 2025, at Wichita State University's National Institute for Aviation Research in Wichita, Kansas. The airframe tested was a production airframe purpose-built to support the test campaign.MQ-9B is GA-ASI's most advanced RPA and includes the SkyGuardian® and SeaGuardian® models as well as the new Protector RG Mk1 that is currently being delivered to the United Kingdom's Royal Air Force (RAF). In addition to the RAF, GA-ASI has MQ-9B procurement contracts with Belgium, Canada, Japan, Taiwan, Poland, India, Denmark, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also been featured in various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, RIMPAC, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More